About: Christopher Adams (scientist)     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Thing, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FChristopher_Adams_%28scientist%29&invfp=IFP_OFF&sas=SAME_AS_OFF

Christopher P. Adams is an American scientist, entrepreneur, and inventor who founded and led (as chief executive officer) multiple biotechnology companies, including Mosaic Technologies and Andarix Pharmaceuticals. Adams has made a notable contribution to the field of genetics as a co-inventor (with Steve Kron) of "bridge amplification," a polymerase chain reaction (PCR) technique that paved the way for development of DNA sequencing and genome sequencing. Geneticist George Church and computational biologist Rob Mitra adapted Adams' and Kron's technique to be used for clonal amplification.

AttributesValues
rdf:type
rdfs:label
  • Christopher Adams (scientist) (en)
rdfs:comment
  • Christopher P. Adams is an American scientist, entrepreneur, and inventor who founded and led (as chief executive officer) multiple biotechnology companies, including Mosaic Technologies and Andarix Pharmaceuticals. Adams has made a notable contribution to the field of genetics as a co-inventor (with Steve Kron) of "bridge amplification," a polymerase chain reaction (PCR) technique that paved the way for development of DNA sequencing and genome sequencing. Geneticist George Church and computational biologist Rob Mitra adapted Adams' and Kron's technique to be used for clonal amplification. (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
dbp:wikiPageUsesTemplate
has abstract
  • Christopher P. Adams is an American scientist, entrepreneur, and inventor who founded and led (as chief executive officer) multiple biotechnology companies, including Mosaic Technologies and Andarix Pharmaceuticals. Adams has made a notable contribution to the field of genetics as a co-inventor (with Steve Kron) of "bridge amplification," a polymerase chain reaction (PCR) technique that paved the way for development of DNA sequencing and genome sequencing. Geneticist George Church and computational biologist Rob Mitra adapted Adams' and Kron's technique to be used for clonal amplification. Adams has spoken about the difficulties he faced in launching Mosaic and getting investors to buy in. He cites being "an African American without a graduate degree" as a major reason he faced skepticism and rejection while attempting to start Mosaic, and that his persistence was a key factor that helped him "overcome investors' reluctance." Adams has said: "Keep in mind, I had no Ph.D. and no MBA and no real serious executive business experience. Couple that with being an African-American and I really didn't fit the mold. I also want to make it plain, though, that I think we're over that now. I do have a track record now. I think that it's almost a non-factor going forward." (en)
prov:wasDerivedFrom
page length (characters) of wiki page
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 59 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software